Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Cellectar Biosciences Inc. (CLRB)

2.13   0.06 (2.9%) 07-22 16:00
Open: 2.09 Pre. Close: 2.07
High: 2.17 Low: 2.09
Volume: 67,467 Market Cap: 20M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.171 - 2.182 2.182 - 2.193
Low: 2.065 - 2.076 2.076 - 2.087
Close: 2.112 - 2.13 2.13 - 2.147

Technical analysis

as of: 2019-07-22 4:56:16 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.60     One year: 2.74
Support: Support1: 2.02    Support2: 1.68
Resistance: Resistance1: 2.22    Resistance2: 2.35
Pivot: 2.13
Moving Average: MA(5): 2.13     MA(20): 2.13
MA(100): 2.24     MA(250): 2.37
MACD: MACD(12,26): -0.02     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 46.38     %D(3): 48.89
RSI: RSI(14): 48.07
52-week: High: 7.15  Low: 1.22  Change(%): -68.2
Average Vol(K): 3-Month: 49571  10-Days: 17175

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CLRB has closed below upper band by 47.8%. Bollinger Bands are 74.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to CLRB's normal range. The bands have been in this narrow range for 22 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 5.32
Shares Float (M) 4.30
% Held by Insiders 3.46
% Held by Institutions 8.07
Shares Short (K) 390
Shares Short P. Month (K)

Stock Financials

EPS -4.184
EPS Est. Current Year -0.920
EPS Est. Next Year -0.870
EPS Est. Next Quarter -0.210
Forward EPS -0.611
Book Value (p.s.) 1.580
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -66.9
Return on Equity (ttm) -154.8
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.205
Qtrly Earnings Growth
Operating Cash Flow (M) -11.07
Levered Free Cash Flow (M) -6.71

Stock Valuations

P/E -0.51
P/E Growth Ratio 0.01
P/BV 1.35
P/CF -1.02

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2018-07-17
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.